Credit Suisse’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,812
Closed -$220K 3336
2022
Q4
$220K Buy
3,812
+896
+31% +$55.3K ﹤0.01% 3152
2022
Q3
$274K Sell
2,916
-10,824
-79% -$1.54M ﹤0.01% 3119
2022
Q2
$3.06M Sell
13,740
-519
-4% -$174K ﹤0.01% 1623
2022
Q1
$7.84M Sell
14,259
-1,101
-7% -$665K 0.01% 1163
2021
Q4
$10.2M Buy
15,360
+7,701
+101% +$5.89M 0.01% 1494
2021
Q3
$6.43M Sell
7,659
-2,550
-25% -$2.59M ﹤0.01% 1862
2021
Q2
$13M Buy
10,209
+1,424
+16% +$1.61M 0.01% 1392
2021
Q1
$9.64M Sell
8,785
-827
-9% -$1.09M ﹤0.01% 1610
2020
Q4
$13.7M Sell
9,612
-501
-5% -$534K 0.01% 1384
2020
Q3
$7.14M Buy
10,113
+8,288
+454% +$6.03M ﹤0.01% 1559
2020
Q2
$1.28M Buy
1,825
+73
+4% +$42.2K ﹤0.01% 2734
2020
Q1
$613K Sell
1,752
-5,260
-75% -$3.73M ﹤0.01% 2990
2019
Q4
$4.41M Sell
7,012
-1,337
-16% -$654K ﹤0.01% 1971
2019
Q3
$2.8M Buy
8,349
+5,955
+249% +$1.91M ﹤0.01% 2216
2019
Q2
$622K Buy
+2,394
New +$479K ﹤0.01% 3272
2019
Q1
Sell
-1,007
Closed -$109K 3991
2018
Q4
$109K Buy
+1,007
New +$170K ﹤0.01% 3759

Other funds holding CDLX

Credit Suisse's CDLX Position: Q1 2023 in Review

Credit Suisse sold out of Cardlytics (CDLX) in Q1 2023, closing a stake of 3,812 shares — an estimated $220K sold.

Credit Suisse first reported a position in CDLX in Q4 2018 and held it in 16 quarters. The position peaked at $13.7M in Q4 2020. 103 funds tracked by Wall St. Rank hold CDLX as of Q1 2023.

  • Credit Suisse reported no remaining Cardlytics position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 3,812 Cardlytics shares in Q1 2023, an estimated $220K.
  • Credit Suisse first reported a position in Cardlytics in Q4 2018 and held it in 16 quarters.
  • Credit Suisse's Cardlytics position peaked at $13.7M in Q4 2020.
  • 103 funds tracked by Wall St. Rank held Cardlytics as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.